EUVIMEDEUVIMED entdecken
Crossref

Impact of dihydropyrimidine dehydrogenase deficiency on oxidative stress index induced by 5-fluorouracil therapy in patients with stage-III colorectal cancer patients

Muhtada Ali Challoob, Omar Khalid Suhail, Mustafa Burhan Ali

Anaesthesia, Pain & Intensive Care · 07.09.2026 · 30 (6) · 690-696

DOI: 10.35975/apic.v30i6.3263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anaesthesia, Pain & Intensive Care, online erschienen am 07.09.2026. Verfasst von Muhtada Ali Challoob und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objective: To the best of our knowledge, no previous studies have examined the valuation of oxidative stress levels in colorectal cancer patients with dehydropyrimidine dehydrogenase (DPD) deficiency who are receiving 5-fluorouracil chemotherapy. The aim of this study is to determine the oxidative stress index (OSI) in stage III colorectal cancer patients with DPD deficiency who are receiving 5-fluorouracil (5-FU) chemotherapy.

Methods

This study comprised 164 male patients with stage III colorectal cancer, all of whom got adjuvant treatment containing of a single cycle of 5-fluorouracil (5-FU). Participants were categorized according to their DPD levels into two groups: 82 males with DPD deficiency and 82 males without DPD deficiency. Multiple regression analyses were carried out to evaluate the OSI and its related elements after adjusting for potential confounders, and receiver operating characteristic (ROC) curve analysis was conduct to evaluate the diagnostic performance of OSI.

Results

The OSI was expressively higher in DPD-deficient patients in comparison with non-DPD-deficient patients (P < 0.001). OSI exhibited a significant negative correlation with DPD levels (r = –0.674, P < 0.001) and white blood cell (WBC) count (r = –0.570, P < 0.001). In multiple regression analysis, DPD level was independently related with OSI (P < 0.001). Additionally, receiver operating characteristic (ROC) curve analysis revealed excellent diagnostic performance of OSI, with an area under the curve (AUC) of 0.989 (95% CI: 0.979–0.999, P < 0.001).

Conclusions

A strong relationship was observed between DPD deficiency and severe systemic oxidative stress in colorectal cancer patients receiving 5-FU chemotherapy.

Zitieren

APA

Challoob, M. A., Suhail, O. K., & Ali, M. B. (2026). Impact of dihydropyrimidine dehydrogenase deficiency on oxidative stress index induced by 5-fluorouracil therapy in patients with stage-III colorectal cancer patients. Anaesthesia, Pain & Intensive Care, 30(6), 690-696. https://doi.org/10.35975/apic.v30i6.3263

Vancouver

Challoob MA, Suhail OK, Ali MB. Impact of dihydropyrimidine dehydrogenase deficiency on oxidative stress index induced by 5-fluorouracil therapy in patients with stage-III colorectal cancer patients. Anaesthesia, Pain & Intensive Care. 2026;30(6):690-696. doi:10.35975/apic.v30i6.3263

BibTeX
@article{Challoob2026,
  author = {Challoob, Muhtada Ali and Suhail, Omar Khalid and Ali, Mustafa Burhan},
  title = {Impact of dihydropyrimidine dehydrogenase deficiency on oxidative stress index induced by 5-fluorouracil therapy in patients with stage-III colorectal cancer patients},
  journal = {Anaesthesia, Pain & Intensive Care},
  year = {2026},
  volume = {30},
  number = {6},
  pages = {690--696},
  doi = {10.35975/apic.v30i6.3263}
}
Kostenlos starten →